Disease & disorder
pigmentary glaucoma
MONDO:1060278
A secondary glaucoma that can develop in pigment dispersion syndrome, in which pigment released from the iris is deposited in the trabecular meshwork, reducing aqueous outflow and raising intraocular pressure, leading to glaucomatous optic neuropathy. It is usually diagnosed between 40 and 50 years of age and occurs more often in men.
Research intelligence
Directly mapped studies only · unique clinical trialsCurrent registry observations. Phase counts may overlap. Study start dates are not registry registration dates. Investigational interventions are not approved-treatment recommendations.
Medications under investigation
Verified disease and drug mappings that co-occur within the same study; not evidence of effectiveness.
Loading mapped interventions…
MONDO disease family
Loading verified ontology relationships…
Recruiting studies by city
Loading research-site locations…
Trial status
Loading…
Trial phase
Loading…
Study start year
Loading…
Investigated drug interventions
Loading…
Drugs being studied
Disease identity and terminology: MONDO. Trial relationships: ClinicalTrials.gov.